BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15018704)

  • 1. Envelope glycoprotein determinants of increased entry in a pathogenic simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) passaged in monkeys.
    Si Z; Gorry P; Babcock G; Owens CM; Cayabyab M; Phan N; Sodroski J
    AIDS Res Hum Retroviruses; 2004 Feb; 20(2):163-73. PubMed ID: 15018704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in human immunodeficiency virus type 1 envelope glycoproteins responsible for the pathogenicity of a multiply passaged simian-human immunodeficiency virus (SHIV-HXBc2).
    Cayabyab M; Karlsson GB; Etemad-Moghadam BA; Hofmann W; Steenbeke T; Halloran M; Fanton JW; Axthelm MK; Letvin NL; Sodroski JG
    J Virol; 1999 Feb; 73(2):976-84. PubMed ID: 9882298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Envelope glycoprotein determinants of neutralization resistance in a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) derived by passage in monkeys.
    Si Z; Cayabyab M; Sodroski J
    J Virol; 2001 May; 75(9):4208-18. PubMed ID: 11287570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralization sensitivity of a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2N) isolated from an infected rhesus macaque with neurological disease.
    Song B; Cayabyab M; Phan N; Wang L; Axthelm MK; Letvin NL; Sodroski JG
    Virology; 2004 Apr; 322(1):168-81. PubMed ID: 15063126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of structural changes in the V2 and V3 loops of the gp120 envelope glycoprotein with acquisition of neutralization resistance in a simian-human immunodeficiency virus passaged in vivo.
    Ye Y; Si ZH; Moore JP; Sodroski J
    J Virol; 2000 Dec; 74(24):11955-62. PubMed ID: 11090196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Envelope glycoprotein determinants of increased fusogenicity in a pathogenic simian-human immunodeficiency virus (SHIV-KB9) passaged in vivo.
    Etemad-Moghadam B; Sun Y; Nicholson EK; Fernandes M; Liou K; Gomila R; Lee J; Sodroski J
    J Virol; 2000 May; 74(9):4433-40. PubMed ID: 10756060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage-tropic simian/human immunodeficiency virus chimeras use CXCR4, not CCR5, for infections of rhesus macaque peripheral blood mononuclear cells and alveolar macrophages.
    Igarashi T; Donau OK; Imamichi H; Dumaurier MJ; Sadjadpour R; Plishka RJ; Buckler-White A; Buckler C; Suffredini AF; Lane HC; Moore JP; Martin MA
    J Virol; 2003 Dec; 77(24):13042-52. PubMed ID: 14645561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD+ T-cell depletion in macaques infected by a simian-human immunodeficiency virus.
    Etemad-Moghadam B; Rhone D; Steenbeke T; Sun Y; Manola J; Gelman R; Fanton JW; Racz P; Tenner-Racz K; Axthelm MK; Letvin NL; Sodroski J
    J Virol; 2001 Jun; 75(12):5646-55. PubMed ID: 11356972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the basis of CD4(+) T-cell depletion in macaques infected by a simian-human immunodeficiency virus.
    Etemad-Moghadam B; Rhone D; Steenbeke T; Sun Y; Manola J; Gelman R; Fanton JW; Racz P; Tenner-Racz K; Axthelm MK; Letvin NL; Sodroski J
    Vaccine; 2002 May; 20(15):1934-7. PubMed ID: 11983249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of the surface envelope glycoprotein associated with virulence of simian-human immunodeficiency virus SHIV(SF33A) molecular clones.
    Chakrabarti LA; Ivanovic T; Cheng-Mayer C
    J Virol; 2002 Feb; 76(4):1588-99. PubMed ID: 11799153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120.
    Hsu M; Harouse JM; Gettie A; Buckner C; Blanchard J; Cheng-Mayer C
    J Virol; 2003 Jan; 77(2):989-98. PubMed ID: 12502815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conserved molecular signatures in gp120 are associated with the genetic bottleneck during simian immunodeficiency virus (SIV), SIV-human immunodeficiency virus (SHIV), and HIV type 1 (HIV-1) transmission.
    Gonzalez MW; DeVico AL; Lewis GK; Spouge JL
    J Virol; 2015 Apr; 89(7):3619-29. PubMed ID: 25589663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SHIV-1157i and passaged progeny viruses encoding R5 HIV-1 clade C env cause AIDS in rhesus monkeys.
    Humbert M; Rasmussen RA; Song R; Ong H; Sharma P; Chenine AL; Kramer VG; Siddappa NB; Xu W; Else JG; Novembre FJ; Strobert E; O'Neil SP; Ruprecht RM
    Retrovirology; 2008 Oct; 5():94. PubMed ID: 18928523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acid deletions are introduced into the V2 region of gp120 during independent pathogenic simian immunodeficiency virus/HIV chimeric virus (SHIV) infections of rhesus monkeys generating variants that are macrophage tropic.
    Imamichi H; Igarashi T; Imamichi T; Donau OK; Endo Y; Nishimura Y; Willey RL; Suffredini AF; Lane HC; Martin MA
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13813-8. PubMed ID: 12370415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of antibodies in guinea pigs and rhesus monkeys against the human immunodeficiency virus type 1 envelope: neutralization of nonpathogenic and pathogenic primary isolate simian/human immunodeficiency virus strains.
    Liao HX; Etemad-Moghadam B; Montefiori DC; Sun Y; Sodroski J; Scearce RM; Doms RW; Thomasch JR; Robinson S; Letvin NL; Haynes BF
    J Virol; 2000 Jan; 74(1):254-63. PubMed ID: 10590113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The V1 region of gp120 is preferentially selected during SIV/HIV transmission and is indispensable for envelope function and virus infection.
    Li Y; Dittmer U; Wang Y; Song J; Sun B; Yang R
    Virol Sin; 2016 Jun; 31(3):207-18. PubMed ID: 27117672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of HIV type 1 envelope glycoprotein proteolytic processing on antigenicity.
    Si Z; Phan N; Kiprilov E; Sodroski J
    AIDS Res Hum Retroviruses; 2003 Mar; 19(3):217-26. PubMed ID: 12689414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High degree of sensitivity of the simian immunodeficiency virus (SIVmac) envelope glycoprotein subunit association to amino acid changes in the glycoprotein 41 ectodomain.
    Marcon L; Sodroski J
    AIDS Res Hum Retroviruses; 1997 Apr; 13(6):441-7. PubMed ID: 9100985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion of quasispecies diversity but no evidence for adaptive evolution of SHIV during rapid serial transfers among seronegative macaques.
    Balfe P; Shapiro S; Hsu M; Buckner C; Harouse JM; Cheng-Mayer C
    Virology; 2004 Jan; 318(1):267-79. PubMed ID: 14972553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid CD4+ T-lymphocyte depletion in rhesus monkeys infected with a simian-human immunodeficiency virus expressing the envelope glycoproteins of a primary dual-tropic Ethiopian Clade C HIV type 1 isolate.
    Cayabyab M; Rohne D; Pollakis G; Mische C; Messele T; Abebe A; Etemad-Moghadam B; Yang P; Henson S; Axthelm M; Goudsmit J; Letvin NL; Sodroski J
    AIDS Res Hum Retroviruses; 2004 Jan; 20(1):27-40. PubMed ID: 15000696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.